abstract |
The present invention provides novel heterocyclic compounds, which are monoacylglycerol lipase (MAGL) inhibitors having general formula (I), wherein A, L 1 , X, m, n, and R 1 to R 4 are as described herein; compositions comprising the compounds; methods of making the compounds; and methods of using the compounds. |